Name: 中東およびアフリカのデング熱治療市場 – 2028年までの業界動向と予測
Brand: Data Bridge Market Research
SKU: 59789
Price: 3500.00 USD
Availability: InStock
Rating: 4.5 (51 reviews)

>中東およびアフリカのデング熱治療市場、株別（DENV-1、DENV-2、DENV-3、DENV-4、その他）、感染経路（蚊から人への感染および母子感染）、タイプ別（薬物療法、支持療法、予防接種、その他）、重症度（単純および重症）、投与経路（経口および非経口）、購入方法（処方薬および市販薬（OTC））、エンドユーザー（病院、専門クリニック、在宅医療、その他）、流通チャネル（病院薬局、小売薬局、オンライン薬局、その他）、国別（南アフリカ、サウジアラビア、UAE、エジプト、イスラエル、その他の中東およびアフリカ）業界動向および2028年までの予測

市場分析と洞察: 中東およびアフリカのデング熱治療市場

デング熱治療市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に23.7%のCAGRで成長し、2028年までに5,349万米ドルに達すると分析しています。市場プレーヤーによる戦略的取り組みとデング熱治療のための集団ワクチン接種プログラムの出現が、デング熱治療市場の主要な推進力となると考えられます。

デング熱は蚊が媒介するウイルス性疾患で、近年WHO（世界保健機関）の管轄地域全体で急速に広がっています。デング熱ウイルスは主にネッタイシマカ属の雌の蚊によって媒介され、ヒトスジシマカからも少量媒介されます。これらの媒介蚊によって媒介される疾患は、チクングニア熱、黄熱病、ジカウイルスです。デング熱は熱帯地方で流行しており、降水量、気温、相対湿度、および地域によってリスクが異なる計画外の急速な都市化によって引き起こされます。

In spite of the controlled steps, the global increase in dengue incidence, along with the increased frequency of localized outbreaks and the potential of aedes species to flourish lead to increase in consumption of the treatment option for dengue treatment and is expected to act as a driver for the dengue treatment market. The cost of dengue treatment are higher as listed in above statement and with more complication related to dengue such as multi organ failure and others can increase the total cost for the therapy results in infected person to avoid proper therapies for dengue treatment thus can act as a restraint for the dengue treatment market. Dengue can be diagnosed traditionally by serological testing but now with the technology upgradation, different ongoing and developed ways are there for virus detection which will create an opportunity for the dengue treatment market. The dengue is a vector borne disease with non-specific drugs such as antipyretic and some antibiotics but the preventive measure and initiatives taken by the different government agencies worldwide is expected to act as a challenge for the dengue treatment market.

The dengue treatment market report provides details of market share, new developments, and impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the dengue treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Dengue Treatment Market Scope and Market Size

The dengue treatment market is segmented on the basis of strains, transmission, type, severity, route of administration, mode of purchase, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of strains, the dengue treatment market is segmented into DENV-1, DENV-2, DENV-3, DENV-4, others. In 2021, DENV-2 segment is dominating the market as this strain is high in prevalence which result in higher infection cases of dengue fever. Although dengue can be caused by other strains too but the most dominant high clinical complication is seen in DENV-2.
On the basis of transmission, the dengue treatment market is segmented into mosquito-to-human transmission and mother-to-child transmission. In 2021, mosquito-to-human transmission segment is dominating in the market as the mosquitoes are the primary vector for the transmission of dengue for the different strains of the virus. When a mosquito bites an infected person it gets infected too and gets the virus in blood, and when a he again bite some other person the virus get transmitted to that person. This is the reason that mosquito-to-human transmission is dominating the market.
On the basis of type, the dengue treatment market is segmented into medication, supportive care, vaccination and others. In 2021, medication segment is dominating in the market as variety of drugs used for treating dengue are being used for the management of dengue fever from the very long time.
On the basis of severity, the dengue treatment market is segmented into uncomplicated and severe. In 2021, uncomplicated segment is dominating in the market the conversion rate of uncomplicated dengue to severe dengue is less than 5% which is the most important reason that the uncomplicated segment is dominating the dengue treatment market.
On the basis of route of administration, the dengue treatment market is segmented into oral and parenteral. In 2021, oral segment is dominating in the market as most of the drug that are taken to treat the symptoms of dengue are taken oral for pain management and fever management.
On the basis of mode of purchase, the dengue treatment market is segmented into prescription and over the counter (OTC). In 2021, prescription segment is dominating in the market as the medication and the supportive care is prescribed by the doctor after the confirmation the patient is infected by the dengue virus and the treatment options consist of antibiotics and other medication which are generally not available as prescribed medication only.
On the basis of end user, the dengue treatment market is segmented into hospitals, specialty clinics, home healthcare and others. In 2021, home healthcare segment is dominating in the market as the symptoms of dengue can be managed at home using medications such as pain relief and fever management drugs after the diagnosis.
On the basis of distribution channel, the dengue treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. In 2021, retail pharmacies segment is dominating in the market as after proper diagnosis of dengue most of the prescriptions by patients are filled in retail pharmacies during the total duration of the treatment cycle of the infection.

Dengue Treatment Market Country Level Analysis

The dengue treatment market is analysed and market size information is provided by the country, strains, transmission, type, severity, route of administration, mode of purchase, end user and distribution channel as referenced above.

The countries covered in the dengue treatment market report are the South Africa, Saudi Arabia, UAE, Egypt, Israel & Rest of Middle East and Africa.

Middle East and Africa is expected to grow with the substantial growth rate in the forecast period of 2021 to 2028 as Middle East and Africa counties are major developing countries. South Africa is expected to dominate in the market in the Middle East and Africa due to growing focus on increasing R&D activities in pharma and biotech sector and increase outsourcing services.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Necessity of Dengue Treatment in Urban Areas and the Strategic Initiatives by Market Players are is Creating New Opportunities for Players in the Dengue Treatment Market

The dengue treatment market also provides you with detailed market analysis for every country growth in particular industry with dengue treatment sales, impact of advancement in the dengue treatment and changes in regulatory scenarios with their support for the dengue treatment market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Dengue Treatment Market Share Analysis

The dengue treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to dengue treatment market.

デング熱治療薬を提供している主な企業としては、武田薬品工業株式会社、サノフィ、エマージェックスワクチン、アビバックス、グラクソ・スミスクライン社、オーロビンド・ファーマUSA、サン・ファーマシューティカル・インダストリーズ社、ペリゴ・カンパニー社、マイラン社、フレゼニウス・カビUSA、ヒクマ・ファーマシューティカルズ社、ファイザー社、ドクター・レディーズ・ラボラトリーズ社、バクスター、テバ・ファーマシューティカル・インダストリーズ社などがあり、その他国内企業も含まれています。DBMRアナリストは、競争上の強みを理解し、各競合他社の競合分析を個別に提供しています。

デング熱研究に資本投資する市場プレーヤーによる戦略的取り組みは、デング熱治療市場におけるデング熱とその治療法のギャップを埋めています。

例えば、

2020年11月、Mylan NVとPfizer Upjohnの2つの事業の統合により、Viatris Inc.が設立されました。この2つの統合は、患者の健康の改善に重点を置きます。Viatris Inc.は、165を超える国と地域の患者に高品質の医薬品を提供するための実証済みの医療、規制、世界的な商業能力を備えた科学的な製造と流通の専門知識を持っています。この新会社の設立により、近い将来、同社の収益が増加するでしょう。

市場プレーヤーによるコラボレーション、合弁事業、その他の戦略により、デング熱治療市場における企業市場が強化され、組織にとってもデング熱治療市場への提供を改善するメリットがもたらされます。

SKU-59789

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

画像をクリックすると拡大します

インタラクティブなデータ分析ダッシュボード
成長の可能性が高い機会のための企業分析ダッシュボード
カスタマイズとクエリのためのリサーチアナリストアクセス
インタラクティブなダッシュボードによる競合分析
最新ニュース、更新情報、トレンド分析
包括的な競合追跡のためのベンチマーク分析のパワーを活用

デモのリクエスト

表のリスト

LIST OF TABLES

TABLE 1 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, PIPELINE ANALYSIS

TABLE 2 THREE PHASES FOR HEALTH PROTECTION OUTLINED BY THE EUROPEAN WORLD HEALTH ORGANIZATION

TABLE 3 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY STRAINS 2019-2028 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA DENV-3 IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA DENV-2 IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA DENV-1 IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA DENV-4 IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA OTHERS IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA MOSQUITO-TO-HUMAN TRANSMISSION IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA MOTHER-TO-CHILD TRANSMISSION IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA OTHERS IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION), BY REGION

TABLE 16 MIDDLE EAST AND AFRICA ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA SUPPORTIVE CARE IN DENGUE TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 19 MIDDLE EAST AND AFRICA VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION), BY REGION

TABLE 21 MIDDLE EAST AND AFRICA OTHERS IN DENGUE TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION), BY REGION

TABLE 22 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY SEVERITY 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA UNCOMPLICATED IN DENGUE TREATMENT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA SEVERE IN DENGUE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION), BY REGION

TABLE 27 MIDDLE EAST AND AFRICA ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION), BY REGION

TABLE 29 MIDDLE EAST AND AFRICA PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA PRESCRIPTION IN DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION), BY REGION

TABLE 32 MIDDLE EAST AND AFRICA OVER THE COUNTER (OTC) IN DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION), BY REGION

TABLE 33 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION), BY REGION

TABLE 35 MIDDLE EAST AND AFRICA HOSPITALS IN DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION), BY REGION

TABLE 36 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION), BY REGION

TABLE 37 MIDDLE EAST AND AFRICA OTHERS IN DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION), BY REGION

TABLE 38 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA DIRECT TENDER IN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION), BY REGION

TABLE 40 MIDDLE EAST AND AFRICA HOSPITAL PHARMACY IN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION), BY REGION

TABLE 41 MIDDLE EAST AND AFRICA ONLINE PHARMACY IN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION), BY REGION

TABLE 42 MIDDLE EAST AND AFRICA HOSPITALS IN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION), BY REGION

TABLE 43 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 54 MIDDLE EAST & AFRICA PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 55 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 56 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 57 MIDDLE EAST & AFRICADENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 58 SOUTH AFRICA DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 59 SOUTH AFRICA DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 60 SOUTH AFRICA DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 SOUTH AFRICA MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 62 SOUTH AFRICA ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 63 SOUTH AFRICA OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 64 SOUTH AFRICA VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 65 SOUTH AFRICA DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 66 SOUTH AFRICA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 67 SOUTH AFRICA ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 68 SOUTH AFRICA PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 69 SOUTH AFRICA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 70 SOUTH AFRICA DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 71 SOUTH AFRICA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 72 SAUDI ARABIA DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 73 SAUDI ARABIA DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 74 SAUDI ARABIA DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 75 SAUDI ARABIA MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 SAUDI ARABIA ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 77 SAUDI ARABIA OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 SAUDI ARABIA VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 SAUDI ARABIA DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 80 SAUDI ARABIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 81 SAUDI ARABIA ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 82 SAUDI ARABIA PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 83 SAUDI ARABIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 84 SAUDI ARABIA DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 85 SAUDI ARABIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 86 UAE DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 87 UAE DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 88 UAE DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 UAE MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 UAE ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 UAE OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 UAE VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 93 UAE DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 94 UAE DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 95 UAE ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 96 UAE PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 97 UAE DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 98 UAE DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 UAE DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 100 ISRAEL DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 101 ISRAEL DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 102 ISRAEL DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 103 ISRAEL MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 104 ISRAEL ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 105 ISRAEL OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 106 ISRAEL VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 107 ISRAEL DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 108 ISRAEL DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 109 ISRAEL ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 110 ISRAEL PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 111 ISRAEL DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 112 ISRAEL DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 113 ISRAEL DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 114 EGYPT DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

TABLE 115 EGYPT DENGUE TREATMENT MARKET, BY TRANSMISSION, 2019-2028 (USD MILLION)

TABLE 116 EGYPT DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 117 EGYPT MEDICATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 118 EGYPT ANTIBIOTICS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 119 EGYPT OTHERS IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 120 EGYPT VACCINATION IN DENGUE TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 121 EGYPT DENGUE TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 122 EGYPT DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 123 EGYPT ORAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 124 EGYPT PARENTERAL IN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 125 EGYPT DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)

TABLE 126 EGYPT DENGUE TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 127 EGYPT DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 128 REST OF MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET, BY STRAINS, 2019-2028 (USD MILLION)

図表一覧

LIST OF FIGURES

FIGURE 1 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET : DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: MARKET END USER GRID

FIGURE 10 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: SEGMENTATION

FIGURE 12 INCREASING INCIDENCE OF DENGUE CASES AND ADVENT OF VACCINATION PROGRAMS ARE DRIVING THE MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 FUNGAL DENGUE TREATMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET

FIGURE 15 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY STRAINS, 2020

FIGURE 16 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY STRAINS, 2020-2028 (USD MILLION)

FIGURE 17 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY STRAINS, CAGR (2021-2028)

FIGURE 18 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY STRAINS, LIFELINE CURVE

FIGURE 19 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY TRANSMISSION, 2020

FIGURE 20 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY TRANSMISSION 2020-2028 (USD MILLION)

FIGURE 21 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY TRANSMISSION, CAGR (2021-2028)

FIGURE 22 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY TRANSMISSION, LIFELINE CURVE

FIGURE 23 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY TYPE, 2020

FIGURE 24 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY TYPE, 2020-2028 (USD MILLION)

FIGURE 25 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY TYPE, CAGR (2020-2028)

FIGURE 26 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY SEVERITY, 2020

FIGURE 28 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY SEVERITY , 2020-2028 (USD MILLION)

FIGURE 29 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY SEVERITY, CAGR (2021-2028).

FIGURE 30 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY SEVERITY, LIFELINE CURVE

FIGURE 31 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 32 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)

FIGURE 33 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)

FIGURE 34 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 35 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, 2020

FIGURE 36 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, 2020-2028 (USD MILLION)

FIGURE 37 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, CAGR (2020-2028)

FIGURE 38 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 39 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY END USER, 2020

FIGURE 40 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 41 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY END USER, CAGR (2020-2028)

FIGURE 42 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 43 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 44 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

FIGURE 45 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)

FIGURE 46 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 47 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 48 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 49 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 50 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 51 MIDDLE EAST & AFRICA DENGUE TREATMENT MARKET: BY STRAINS (2021-2028)

FIGURE 52 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET: COMPANY SHARE 2020 (%)

詳細情報を見る

調査方法

データ収集と基準年分析は、大規模なサンプルサイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データマイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データモデルには、ベンダーポジショニンググリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニンググリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダーシェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータスタイルでいくつでも追加できます。当社のアナリストチームは、粗い生の Excel ファイルピボットテーブル (ファクトブック) でデータを提供したり、レポートで利用可能なデータセットからプレゼンテーションを作成するお手伝いをしたりすることもできます。